What to know about pregnancy for women with kidney disease
UC doctor addresses common misconceptions
When counseling women with kidney disease about pregnancy, nephrologists and women’s health providers must emphasize intentionality, Healio reports.
That means consistent use of a reliable birth control method and discussions with her health care team before attempting to conceive — whether a woman is on dialysis or is a kidney donor or recipient.
“We need shared decision-making with women rather than a paternalistic attitude,” said Silvi Shah, MD, MS, FASN,FACP, recently to Healio. She is an associate professor in the nephrology and hypertension division of the Department of Internal Medicine at the University of Cincinnati College of Medicine and a specialist in women’s health in kidney disease.
“We have to remember that childbearing is important," said Shah. "And we have to counsel women with kidney disease about all the risks and then support them in whatever decision they take.”
She said pregnancy for women with kidney disease is considered high risk. She spoke with Healio about the relationship between kidney function and pregnancy, considerations for women with a kidney transplant, common misconceptions about conception and breastfeeding and more.
Featured image at top: Pregnant woman's body shown in black and white. Photo/Provided.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.